Microbiotica
Founded 2016 · 53 employees on LinkedIn · 3 known investors
Microbiotica develops defined live biotherapeutic products based on microbiome science for immuno-oncology and inflammatory bowel disease treatment. The company uses a clinic-led discovery platform to identify specific bacteria linked to patient outcomes and target patient populations.
Investors · 3
Competitors · 2
by search overlap
Resilient Biotics7 shared keywords
bio7 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Companies competing with Microbiotica for the same Google search keywords, organic and paid, via search-intersection analysis.
Companies House · registry record
View on Companies House ↗- Registered name
- MICROBIOTICA LIMITED
- Company number
- 10269808
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 8 Jul 2016
- Registered office
- Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 7 Jul 2026 · next due 21 Jul 2027
Current officers · 7
- Carmine Daniel Circelli — director, appointed 12 Jan 2023
- Viet-Anh Anne Horgan — director, appointed 1 May 2025
- Trevor David Lawley — director, appointed 8 Jul 2016
- Mark Royston Quick — director, appointed 4 Mar 2022
- Johannes Gerardus Christiaan Petrus Schikan — director, appointed 1 Feb 2021
- Timothy Sharpington — director, appointed 1 Jan 2023
- Ip2ipo Services Limited — corporate director, appointed 15 Dec 2016
Source: Companies House public register · retrieved 7 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Microbiotica do?
- Microbiotica develops defined live biotherapeutic products based on microbiome science for immuno-oncology and inflammatory bowel disease treatment. The company uses a clinic-led discovery platform to identify specific bacteria linked to patient outcomes and target patient populations.
- Who are Microbiotica's investors?
- Microbiotica's investors include Cambridge Innovation Capital, Seventure Partners, DCVC (Data Collective).